PATENT CLAIM ANALYSIS

Application Number: 15778220
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "027000"]

Abstract:
This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.

Claim (Index 5):
The complex of  claim 4 , wherein the crystalline form has an X-ray powder diffraction pattern comprising peaks at scattering angles (2\u03b8) of 3.61\u00b0\u00b10.2\u00b0, 13.35\u00b0\u00b10.2\u00b0, 17.84\u00b0\u00b10.2\u00b0, 18.22\u00b0\u00b10.2\u00b0, 19.92\u00b0\u00b10.2\u00b0 and 21.43\u00b0\u00b10.2\u00b0; or\n wherein the crystalline form has an X-ray powder diffraction pattern comprising peaks at scattering angles (2\u03b8) of 3.61\u00b0\u00b10.2\u00b0, 7.14\u00b0\u00b10.2\u00b0, 13.35\u00b0\u00b10.2\u00b0, 17.84\u00b0\u00b10.2\u00b0, 18.22\u00b0\u00b10.2\u00b0, 19.92\u00b0\u00b10.2\u00b0, 21.43\u00b0\u00b10.2\u00b0 and 22.70\u00b0\u00b10.2\u00b0; or \n wherein the crystalline form has an X-ray powder diffraction pattern comprising peaks at scattering angles (2\u03b8) of 3.61\u00b0\u00b10.2\u00b0, 7.14\u00b0\u00b10.2\u00b0, 11.44\u00b0\u00b10.2\u00b0, 11.84\u00b0\u00b10.2\u00b0, 13.35\u00b0\u00b10.2\u00b0, 16.33\u00b0\u00b10.2\u00b0, 16.71\u00b0\u00b10.2\u00b0, 17.16\u00b0\u00b10.2\u00b0, 17.84\u00b0\u00b10.2\u00b0, 18.22\u00b0\u00b10.2\u00b0, 19.92\u00b0\u00b10.2\u00b0, 21.43\u00b0\u00b10.2\u00b0, 22.70\u00b0\u00b10.2\u00b0 and 22.96\u00b0\u00b10.2\u00b0; or \n wherein the crystalline form has an X-ray powder diffraction pattern comprising peaks at scattering angles (2\u03b8) of 3.61\u00b0\u00b10.2\u00b0, 7.14\u00b0\u00b10.2\u00b0, 11.44\u00b0\u00b10.2\u00b0, 11.84\u00b0\u00b10.2\u00b0, 13.35\u00b0\u00b10.2\u00b0, 16.33\u00b0\u00b10.2\u00b0, 16.71\u00b0\u00b10.2\u00b0, 17.16\u00b0\u00b10.2\u00b0, 17.84\u00b0\u00b10.2\u00b0, 18.22\u00b0\u00b10.2\u00b0, 18.52\u00b0\u00b10.2\u00b0, 19.92\u00b0\u00b10.2\u00b0, 21.43\u00b0\u00b10.2\u00b0, 21.74\u00b0\u00b10.2\u00b0, 22.70\u00b0\u00b10.2\u00b0, 22.96\u00b0\u00b10.2\u00b0, 23.75\u00b0\u00b10.2\u00b0, 24.31\u00b0\u00b10.2\u00b0, 25.07\u00b0\u00b10.2\u00b0, 25.84\u00b0\u00b10.2\u00b0, 26.50\u00b0\u00b10.2\u00b0, 27.75\u00b0\u00b10.2\u00b0, 28.61\u00b0\u00b10.2\u00b0, 29.25\u00b0\u00b10.2\u00b0, 29.44\u00b0\u00b10.2\u00b0, 30.17\u00b0\u00b10.2\u00b0, 30.99\u00b0\u00b10.2\u00b0, 31.59\u00b0\u00b10.2\u00b0, 32.40\u00b0\u00b10.2\u00b0, 32.81\u00b0\u00b10.2\u00b0, 34.32\u00b0\u00b10.2\u00b0, 34.79\u00b0\u00b10.2\u00b0, 35.43\u00b0\u00b10.2\u00b0, 36.09\u00b0\u00b10.2\u00b0 and 38.03\u00b0\u00b10.2\u00b0; or \n wherein the crystalline form has an X-ray powder diffraction pattern substantially the same as shown in  FIG. 2 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14627693', '15804074', '13158724', '12503225', '13530645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7706928575483797
- 35 USC 102 Novelty (BERT): 0.5075204641117332
- Combined Prediction Score: 0.7443756182047151
- Mean Citation Score: 259.12978200000003
- Max Citation Score: 287.61752
- Similarity Product: 219.2197759329796

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test